Solteq reported its first comparable revenue growth in eight quarters, driven by the Utilities segme...
Profitability was mainly in line with our expectations and didn’t offer surprises.
Redeye leaves a short comment following OncoZenge’s announcement of having received the third tranch...
Marimekko's fourth quarter revenue missed our estimates slightly, weighed down by wholesale weakness...
Raute achieved an EBITDA margin of 15.8% in Q4’25, which it may not be able to produce again in the ...
Finnair’s Q4 earnings reached a record high especially due to efficient operations.
Redeye considers Polygiene’s Q4'25 figures to be soft, missing our expectations by 18% on top-line, ...
As anticipated, Genovis’ year-end report showcased robust top-line momentum, with sharp sales growth...
Redeye comments on Litium’s Q4, which showed solid momentum with 18% ARR growth and net sales above ...
* Sales 2% and adj. EBIT -31% vs. ABGSCe * Order intake SEK 251m, above expectations * Likely negati...
* Q4 sales SEK 18m (-14% y-o-y), -16% vs. ABGSCe * EBIT adj.
Atria reported Q4 adjusted EBIT of EUR 14.0m, 3% below LSEG Data & Analytics consensus.
Redeye is encouraged by Nekkar’s financial recovery during the fourth quarter, which posted a 30% be...
Redeye provides its initial take on Ferroamp’s Q4 numbers, which presented strong sales growth and s...
* Solid report driven by very strong U.S. performance * Adj.
Redeye comments on Embracer’s Q3-results which were better than expected driven by solid results in ...
RaySearch delivered a strong Q4, with record sales above consensus estimates and record EBIT, also a...
* Adj. EBIT 1% vs consensus * 10% organic growth, order book +18% y-o-y * We expect estimates to be ...
Devyser reached a 25% EBIT margin and record sales, with strong operating cash flow.
* Sales -1% and adj. EBITA -5% vs ABGSCe * Gross profit of SEK 21.
